No Detail Found!

Preparation and evaluation of alendronate sodium solid lipid nanoparticles with high oral bioavailability in rats

Author(s)
Ruijin Geng School of Pharmaceutical Science, Nanchang University,Nanchang,China
Le Wu Department of Pharmaceutics, School of Medicine, Jiaxing University,Jiaxing,China;School of Pharmaceutical Science, Nanchang University,Nanchang,China
Haipeng Wang School of Pharmaceutical Science, Nanchang University,Nanchang,China
Shuilin Sun School of Pharmaceutical Science, Nanchang University,Nanchang,China
Huiming Huang School of Pharmaceutical Science, Nanchang University,Nanchang,China
Yuanzhen Xiong School of Pharmaceutical Science, Nanchang University,Nanchang,China
Baogang Xie Department of Pharmaceutics, School of Medicine, Jiaxing University,Jiaxing,China;School of Pharmaceutical Science, Nanchang University,Nanchang,China
Abstract
Low oral bioavailability of alendronate sodium (ALE) significantly limits its clinical application. However, few studies focus on preparing ALE solid lipid nanoparticles (ALE-SLNs) and investigating its oral bioavailability in vivo due to highly hydrophilic property of ALE. In this study, ALE-SLNs were prepared through high-speed shearing combined with ultrasonic treatment method. ALE-SLNs were evaluated by average particle size, electric potential, encapsulation efficiency (EE), and drug loading (DL). Our results showed that the average EE and DL reached 62.56±0.94% and 6.26±0.09% (n=3), respectively. 120.27±1.17nm, 0.29±0.13 and -19.1±0.27 mV (n=3) were obtained in the average particle size, polydispersity index and zeta potential, respectively. The stability test showed that ALESLNs remained stable for more than 2 months at 4°C. After oral administration of ALE-SLNs (4.5mg/kg), the bioavailability was 2.17 times higher than that of ALE solution (86.82±3.6 vs 40.1±1.3µg) in rats. Our results indicate that high-speed shearing combined with the ultrasound method is simple and rapid to prepare ALE-SLNs. SLNs can improve the oral delivery of ALE in rats, which may exert beneficial effects in clinical applications.
Publication Details
Page(s) 493-499
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Preparation, alendronate sodium, urinary excretion of drug, oral bioavailability, solid lipid nanoparticles
References
Ban C,Jo M,Park YH,Kim JH,Han JY,Lee KW,Kweon DH,Choi YJ .2020 .Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Food Chem, 302 : 125328.
Boulenc X,Breul T,Gautier JC,Saudemon P,Joyeux H,Roques C,Berger Y,Fabre G Y .1995 .Sodium lauryl sulfate increases tiludronate paracellular transport using human epithelial caco-2 monolayers. Int. J. Pharm., 123(1) : 71-83.
Dolatabadi JEN,Hamishehkar H,Eskandani M,Valizadeh H M .2014 .Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles. Colloid Surface B., 117(5) : 21-28.
Ezra A,Hoffman A,Breuer E,Alferiev IS,Monkkonen J,El Hanany-Rozen N,Weiss G,Stepensky D,Gati I,Cohen H .2000 .A peptide prodrug approach for improving bisphosphonate oral absorption. J. Med, 43(20) : 3641-3652.
Han HK,Shin HJ,Ha DH .2012 .Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur. J. Pharm. Sci., 46(5) : 500-507.
Janner M,Muhlbauer RC,Fleisch H RC .1991 .Sodium EDTA enhances intestinal absorption of two bisphosphonates. Calcif. Tissue. Int., 49(4) : 280-283.
Kline WF,Matuszewski BK .1992 .Improved determination of the bisphosphonate alendronate in human plasma and urine by automated precolumn derivatization and high-performance liquid chromatography with fluorescence and electrochemical detection. J. Chromatogr., 583(2) : 183-193.
La-Beck NM,Liu X,Shmeeda H,Shudde C,Gabizon AA C .2021 .Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment. Semin Cancer Biol, 68 : 175-185.
Li C,Zhou K,Chen D,Xu W,Tao Y,Pan Y,Meng K,Shabbir MAB,Liu Q,Huang L Q .2019 .Solid lipid nanoparticles with enteric coating for improving stability, palatability and oral bioavailability of enrofloxacin. Int. J. Nanomedicine., 14 : 1619-1631.
Luo RB,Lin T,Zhong HM,Yan SG,Wang JA .2014 .Evidence for using alendronate to treat adult avascular necrosis of the femoral head: A systematic review. Med. Sci. Monit, 20 : 2439-2447.
Magenheim B,Levy MY,Benita S MY .1993 .A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure. Int. J. Pharm., 93(1-3) : 115-123.
Maher S,Leonard TW,Jacobsen J,Brayden DJ J .2009 .Safety and efficacy of sodium caprate in promoting oral drug absorption: From in vitro to the clinic. Adv. Drug Deliver Rev., 61(15) : 1427-1449.
Men L,Zhao YL,Hao J,Pan XY,Yu ZG .2010 .Determination of alendronate sodiumin human urine by HPLC with fluorescence detector. Chin, 45(19) : 1492-1495.
Nakaya Y,Takaya M,Hinatsu Y,Alama T,Kusamori K,Katsumi H,Sakane T,Yamamoto A .2016 .Enhanced oral delivery of bisphosphonate by novel absorption enhancers: improvement of intestinal absorption of alendronate by n-acyl amino acids and nacyl taurates and their absorption-enhancing mechanisms. J. Pharm. Sci., 105(12) : 3680-3690.
Nakhla M,Denker AE,Connor JD,Carpenter TO,Walson PD,Porras AG,Matthews CZ,Larson P,Freeman A,Wagner JA .2011 .Bioavailability and shortterm tolerability of alendronate in glucocorticoidtreated children. Clin. Ther, 33(10) : 1516-1523.
Partridge GJ,Rao S,Woolley LD,Pilmer L,Lymbery AJ,Prestidge CA,Toxicol C. .2019 .Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi. , 218 : 14-20.
Posadowska U,Parizek M,Filova E,Wlodarczyk-Biegun M,Kamperman M,Bacakova L,Pamula E .2015 .Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate. Int. J. Pharm., 485(1-2) : 31-40.
Raiman J,Tormalehto S,Yritys K,Junginger HE,Monkkonen J .2003 .Effects of various absorption enhancers on transport of clodronate through Caco-2 cells. Int. J. Pharm., 261(1-2) : 129-136.
Mehnert W Schwarz C .1999 .Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J. Microencapsul., 16(2) : 205-213.
Wang Y,Yang J,Wang HP,Yu MJ,Huang HM,Xie BG .2017 .Determination of alendronate sodium in rat urinary by pre-column derivation HPLC-UV method and its application to pharmacokinetics. Chin. J. Pharm. Anal., 37(05) : 832-838.
Xiao L,Yi T,Liu Y .2013 .A new self-microemulsifying mouth dissolving film to improve the oral bioavailability of poorly water soluble drugs. Drug. Dev, 39(9) : 1284-1290.
Yang J,Sun LG,Bai XZ,Zhou HT .2002 .Simultaneous determination of 18 amino acids by reversed phase high performance liquid chromatography with precolumn phenylisothiocyanate derivatization. Chin. J. Chromatogr., 20(4) : 369-371.
Yun MH,Kwon KI .2006 .High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humans. J. Pharm. Biomed. Anal., 40(1) : 168-172.
0

Citations

0

Downloads

81

Views